• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Ocular Melanoma

Ocular Melanoma - 43 Studies Found

Completed : A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma.
: Uveal Melanoma
: 2015-11-06
: Drug: LXS196
Terminated : Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
: Uveal Melanoma
: 2009-06-25
: Biological: autologous dendritic cells electroporated with mRNA Autologous mature monocyte-derived dendr
Completed : Treatment With Intravitreal Avastin for Large Uveal Melanomas
: Uveal Melanoma
: 2008-01-08
: Drug: AVASTIN a single injection of Avastin at the outpatient clinic. This will be done as follows: the
Completed : Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
: Uveal Melanoma
: 2014-08-20
: Drug: Crizotinib An anti-cancer drug acting as an ALK (ana
Recruiting : Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma
: Uveal Melanoma
: 2009-12-15
: Drug: CP-675,206 Patients will receive CP-675,206 at 15 mg/kg administered intravenously on day 1 of eve
Completed : Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
: Uveal Melanoma
: 2007-04-11
: Procedure: Intraoperative ultrasonography Intraoperative ultrasonography will be used to determine plaqu
Recruiting : Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma
: Uveal Melanoma
: 2009-03-30
: Radiation: Hypofractionated linear accelerator radiotherapy 10 fractions of stereotactic linear accelera
Completed : RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
: Uveal Melanoma
: 2010-12-01
: Drug: RAD001 (Everolimus) and Pasireotide (SOM230) LAR Patients will be treated with SOM-230 (pasireotid
Active, not recruiting : A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma
: Uveal Melanoma
: 2011-06-14
:
  • Drug: Placebo two tablets in t

Terminated : A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma
: Uveal Melanoma
: 2013-02-21
:
  • Drug: AEB071 Twice-daily doses

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.